Immutep Limited (IMMP)
NASDAQ: IMMP · Real-Time Price · USD
2.090
+0.020 (0.97%)
Jan 31, 2025, 4:00 PM EST - Market closed
Immutep Employees
Immutep had 31 employees as of June 30, 2014.
Employees
31
Change
n/a
Growth
n/a
Revenue / Employee
$82,687
Profits / Employee
-$919,373
Market Cap
313.18M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jun 30, 2014 | 31 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 89,900 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
| Novo Nordisk | 64,319 |
IMMP News
- 1 day ago - Immutep Quarterly Activities Report Q2 FY25 - GlobeNewsWire
- 4 days ago - Immutep Limited: Continuing To Make The Case For Eftilagimod - Seeking Alpha
- 6 weeks ago - Immutep Announces Initial Safety Data from First-in-Human Phase I Trial Evaluating IMP761 - GlobeNewsWire
- 7 weeks ago - Immutep Reports Promising New Data in Head and Neck Cancer at ESMO Immuno-Oncology 2024 - GlobeNewsWire
- 2 months ago - Immutep: Potential Of Efti As New Standard Of Care For NSCLC Patients - Seeking Alpha
- 2 months ago - Immutep's Lead Cancer Drug Shows Promising 2-Year Survival Data In Lung Cancer Trial - Benzinga
- 2 months ago - Immutep's Efti Shows Excellent Survival Data from INSIGHT-003 Trial in Non-Small Cell Lung Cancer - GlobeNewsWire
- 3 months ago - Immutep Quarterly Activities Report Q1 FY25 - GlobeNewsWire